REFERENCES
- Porter S., Bruno C. H. Lieberman, L. Lachman, J. SchwartzCoating of pharmaceutical dosage forms. Pharmaceutical Dosage Forms: Tablets, . 2nd Ed., Marcel Dekker, New York 1990; Vol. 3: 77–158
- Sun Y., Hsu S., Lai J. Transport properties of ionic drugs in the ammonio methacrylate copolymer membranes. Pharm. Res. 2001; 18(3)304–310
- Dittgen M., Durrani M., Lehmann K. Acrylic polymers: a review of pharmaceutical applications. S. T. Pharm. Sci. 1997; 7(6)403–437
- Amighi K., Moes A. Evaluation of thermal and film forming properties of acrylic aqueous polymer dispersion blends: application to the formulation of sustained release film coated theophylline pellets. Drug Dev. Ind. Pharm. 1995; 21(20)2355–2369
- Steward P., Hearn J., Wilkinson M. Studies on permeation through polymer latex films. I. Films containing no or only low levels of additives. Polym. Int. 1995; 38(1)1–12
- , Rohm America; Eudragits for Sustained Release. 1997 Piscatway, NJ.
- Okor R.S. Effect of polymer cation content on certain film properties. J. Pharm. Pharmacol. 1981; 34: 83–86
- Lehmann K. J.W. McGinityChemistry and application properties of polymethacrylate coating system. Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, . 2nd Ed., Marcel Dekker, New York 1997; 101–176
- Li S., Feld K., Kowarski C., Chana R. Preparation of a controlled release drug delivery system of indomethacin. Drug Dev. Ind. Pharm. 1994; 20(7)1121–1145
- Bianchini R., Bruni G., Gazzaniga A., Vecchio C. d-Indobufen extended release pellets prepared by coating with aqueous polymer dispersions. Drug Dev. Ind. Pharm. 1993; 19(16)2021–2041
- Husson I., Leclerc B., Spenlehauer G., Villard M., Couarrazae G. Modeling of drug release from pellets coated with an insoluble polymeric membrane. J. Control. Release 1991; 17(2)163–173
- Hamed E., Sakr A. Application of multiple response optimization technique to extended release formulations design. J. Control. Release 2001; 73(2–3)329–338
- Miyamoto Y., Ryu A., Sugawara S., Miyajima M., Matsui M., Takayama K., Nagai T. Optimization of the granulation process for designing tablets. Chem. Pharm. Bull. 1998; 46(9)1432–1437
- Sastry S., Reddy I., Indra K., Khan M. Atenolol gastrointestinal therapeutic system: optimization of formulation variables using response surface methodology. J. Control. Release 1997; 45(2)121–130
- Singh S., Dodge J., Durrani M., Khan M. Optimization and chracterization of controlled release pellets coated with an experimental latex: I. Anionic drug. Int. J. Pharm. 1995; 125(2)243–255
- Turkoglu M., Sakr A. Mathematical modeling and optimization of a rotary fluidized bed process. Int. J. Pharm. 1992; 88: 75–87
- Myers R., Montgomery D. Response Surface Methodology: Process and Product Optimization Using Designed Experiments. 1st Ed., Wiley Interscience Publication, New York 1995; 208–265
- , United States Food and Drug Administration (FDA); Guidance for Industry, Dissolution testing of immediate release solid oral dosage forms, August, 1997.
- Moore J., Flanner H. Mathematical comparison of dissolution profiles. Pharm. Tech. 1996; June: 64–74
- Hutchings D., Kuzmak B., Sakr A. Processing considerations for an EC latex coating system: influence of curing time and temperature. Pharm. Res. 1994; 11(10)1474–1878
- Bodmeier R., Paeratakul O. The effect of curing on drug release and morphological properties of ethylcellulose pesudolatex coated beads. Drug. Dev. Ind. Pharm. 1994; 20(9)1517–1533